Zobrazeno 1 - 9
of 9
pro vyhledávání: '"S A, Ezzone"'
Autor:
M D Scholl, D C Young, M B Tighe, K S Theil, P S Belt, Belinda R. Avalos, Sam Penza, Edward A. Copelan, Patrick Elder, T P Bechtel, S A Ezzone
Publikováno v:
Bone Marrow Transplantation. 26:1037-1043
Results in 164 patients who underwent allogeneic marrow transplantation following busulfan and cyclophosphamide over a 15 year period were analyzed. Age (median 37, range 14-66 years) did not significantly affect the incidence of graft-versus-host di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::370b8543fbc79a450f4fd11628fd45e5
https://doi.org/10.1038/sj.bmt.1702689
https://doi.org/10.1038/sj.bmt.1702689
Autor:
Scholl, S A Ezzone, Sam Penza, Belinda R. Avalos, Edward A. Copelan, P S Belt, Patrick Elder, T P Bechtel
Publikováno v:
Bone Marrow Transplantation. 25:1219-1222
Prognostic factors in 42 patients aged 11 to 62 (median 46) years, with myelodysplastic syndrome (MDS) or after leukemic transformation, who underwent allogeneic marrow transplantation between 1984 and 1999 were analyzed. Thirty-six had advanced dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::679f021b511777836ef70dd57ace7a90
https://doi.org/10.1038/sj.bmt.1702432
https://doi.org/10.1038/sj.bmt.1702432
Autor:
Matt Kalaycio, Edward A. Copelan, Scholl, G L Risley, Brad Pohlman, Belinda R. Avalos, Steven Andresen, Marlene Goormastic, Sam Penza, T P Bechtel, Lynn O'Donnell, D C Young, M B Tighe, Patrick Elder, S A Ezzone, Brian J. Bolwell
Publikováno v:
Bone Marrow Transplantation. 25:1243-1248
The purpose of the study was to determine the toxicities and effectiveness of a novel preparative regimen of busulfan (Bu) 14 mg/kg, etoposide 50 or 60 mg/kg, and cyclophosphamide (Cy) 120 mg/kg in non-Hodgkin's lymphoma (NHL) and to analyze results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f88d961a01ffb4223728fa054ec5924b
https://doi.org/10.1038/sj.bmt.1702433
https://doi.org/10.1038/sj.bmt.1702433
Autor:
Belinda R. Avalos, S A Ezzone, G L Risley, T P Bechtel, D D Marshall, L C Lasky, Patrick Elder, Edward A. Copelan, Sarah K. Ceselski, Sam Penza, J. L. Klein, D M Hehmeyer, M D Scholl
Publikováno v:
Journal of Clinical Oncology. 15:759-765
PURPOSE We analyzed the safety and effectiveness of high-dose etoposide (2 g/m2) followed by granulocyte colony-stimulating factor (G-CSF) as a peripheral-blood progenitor cell (PBPC) mobilization regimen and assessed extent of tumor reduction in pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a98af3c368bc339b8c682b80ebdd577c
https://doi.org/10.1200/jco.1997.15.2.759
https://doi.org/10.1200/jco.1997.15.2.759
Autor:
T P Bechtel, Patrick Elder, S Hoshaw-Woodard, Sherif S. Farag, S A Ezzone, Guido Marcucci, Thomas S. Lin, M D Scholl, Stanley Lemeshow, Edward A. Copelan, Sam Penza, Belinda R. Avalos
Publikováno v:
Bone Marrow Transplantation. 34:85-87
The use of VP-16 for stem cell mobilization has been cited as a significant risk factor for the development of therapy-related myelodysplasia/leukemia (tMDS/tAML) following autologous transplantation. The present study analyzed a large cohort of pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7415bcf4fc85736960fc676da65ae821
https://doi.org/10.1038/sj.bmt.1704532
https://doi.org/10.1038/sj.bmt.1704532
Autor:
M D Scholl, Belinda R. Avalos, Patrick Elder, S A Ezzone, Sam Penza, T P Bechtel, Edward A. Copelan
Publikováno v:
Bone marrow transplantation. 27(11)
Long-term outcome was analyzed in 28 patients transplanted between 1989 and 1992 following busulfan and cyclophosphamide and who had busulfan levels studied. While there was no significant correlation of busulfan levels with diagnosis, patients who h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f16a15e51c57a907edb6fed41ba4de18
https://pubmed.ncbi.nlm.nih.gov/11551021
https://pubmed.ncbi.nlm.nih.gov/11551021
Autor:
S A, Ezzone
Publikováno v:
Clinical journal of oncology nursing. 3(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::56672fd498b8af3fc2e1ad24e28789dd
https://pubmed.ncbi.nlm.nih.gov/10703326
https://pubmed.ncbi.nlm.nih.gov/10703326
Autor:
E A, Copelan, S L, Penza, P J, Elder, P S, Belt, M D, Scholl, D M, Hehmeyer, S A, Ezzone, T P, Bechtel, B R, Avalos
Publikováno v:
Bone marrow transplantation. 18(5)
Between March 1984 and March 1995, 76 patients with advanced acute myelogenous, acute lymphoblastic, or chronic myelogenous leukemia underwent allogeneic marrow transplantation from HLA-identical or one-antigen mismatched sibling or unrelated donors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f3e9d9e10be01709391446ece82744dc
https://pubmed.ncbi.nlm.nih.gov/8932844
https://pubmed.ncbi.nlm.nih.gov/8932844
Autor:
J L, Klein, B R, Avalos, P, Belt, C A, Taylor, S A, Ezzone, M D, Scholl, J, Fisher, D, Young, E A, Copelan
Publikováno v:
Bone marrow transplantation. 17(4)
Two major problems of unrelated donor transplantation have been an increased incidence of GVHD and graft failure. Even with HLA identity by microlymphocytotoxicity assay and non-reactive MLC, URD marrow transplant recipients have a higher incidence o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e774967ae2b7cfe826e668d91bb195a9
https://pubmed.ncbi.nlm.nih.gov/8722342
https://pubmed.ncbi.nlm.nih.gov/8722342